| 1 | MRK | Merck & Co. | Pharmaceuticals | 50 | $148 | +11.6% | +13.1% | Constructive base | Watch |
| 2 | INCY | Incyte | Biotechnology | 48 | $126 | +3.0% | +4.5% | Constructive base | Watch |
| 3 | GILD | Gilead Sciences | Biotechnology | 47 | $146 | +6.4% | +7.8% | Constructive base | Watch |
| 4 | IQV | IQVIA | Life Sciences Tools & Services | 45 | $256 | +3.5% | +5.0% | Constructive base | Watch |
| 5 | MRNA | Moderna | Biotechnology | 45 | $138 | +125.8% | +127.3% | Blowoff risk | Do not chase |
| 6 | TECH | Bio-Techne | Life Sciences Tools & Services | 43 | $72.30 | -1.3% | +0.2% | Repairing | Observe |
| 7 | JNJ | Johnson & Johnson | Pharmaceuticals | 43 | $269 | +2.0% | +3.5% | Constructive base | Watch |
| 8 | PFE | Pfizer | Pharmaceuticals | 42 | $27.91 | +3.4% | +4.8% | Constructive base | Watch |
| 9 | WAT | Waters Corporation | Life Sciences Tools & Services | 36 | $409 | -3.0% | -1.5% | Repairing | Observe |
| 10 | TMO | Thermo Fisher Scientific | Life Sciences Tools & Services | 35 | $607 | -1.1% | +0.4% | Repairing | Observe |
| 11 | VTRS | Viatris | Pharmaceuticals | 34 | $16.55 | +0.2% | +1.7% | Below 50d | Avoid unless reclaiming |
| 12 | BIIB | Biogen | Biotechnology | 33 | $213 | +3.0% | +4.5% | Repairing | Observe |
| 13 | DHR | Danaher Corporation | Life Sciences Tools & Services | 29 | $205 | -2.6% | -1.1% | Repairing | Observe |
| 14 | REGN | Regeneron Pharmaceuticals | Biotechnology | 28 | $805 | -0.5% | +1.0% | Repairing | Observe |
| 15 | BMY | Bristol Myers Squibb | Pharmaceuticals | 27 | $64.40 | -0.3% | +1.2% | Repairing | Observe |
| 16 | CRL | Charles River Laboratories | Life Sciences Tools & Services | 21 | $279 | -2.6% | -1.1% | Repairing | Observe |
| 17 | A | Agilent Technologies | Life Sciences Tools & Services | 20 | $146 | -4.1% | -2.6% | Repairing | Observe |
| 18 | DXCM | Dexcom | Diabetes devices | 20 | $84.56 | -7.0% | -5.5% | Repairing | Observe |
| 19 | VRTX | Vertex Pharmaceuticals | Biotechnology | 20 | $522 | -3.0% | -1.5% | Repairing | Observe |
| 20 | ABBV | AbbVie | Biotechnology | 18 | $250 | -1.6% | -0.1% | Below 50d | Avoid unless reclaiming |
| 21 | ZTS | Zoetis | Pharmaceuticals | 15 | $73.39 | -4.1% | -2.6% | Below 50d | Avoid unless reclaiming |
| 22 | AZN | AstraZeneca | Pharma | 15 | $158 | -1.8% | -0.3% | Below 50d | Avoid unless reclaiming |
| 23 | AMGN | Amgen | Biotechnology | 12 | $393 | -6.6% | -5.1% | Below 50d | Avoid unless reclaiming |
| 24 | LLY | Lilly (Eli) | Pharmaceuticals | 12 | $1128 | -8.6% | -7.1% | Below 50d | Avoid unless reclaiming |
| 25 | MTD | Mettler Toledo | Life Sciences Tools & Services | 8 | $1303 | -10.8% | -9.3% | Below 50d | Avoid unless reclaiming |